Investigational Drug Information for Lenabasum
✉ Email this page to a colleague
What is the development status for investigational drug Lenabasum?
Lenabasum is an investigational drug.
There have been 6 clinical trials for Lenabasum.
The most recent clinical trial was a Phase 2 trial, which was initiated on December 18th 2017.
The most common disease conditions in clinical trials are Dermatomyositis, Fibrosis, and Cystic Fibrosis. The leading clinical trial sponsors are Corbus Pharmaceuticals Inc., Cystic Fibrosis Foundation Therapeutics, and National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS).
There are seven US patents protecting this investigational drug and ninety-two international patents.
Summary for Lenabasum
| US Patents | 7 |
| International Patents | 92 |
| US Patent Applications | 175 |
| WIPO Patent Applications | 78 |
| Japanese Patent Applications | 12 |
| Clinical Trial Progress | Phase 2 (2017-12-18) |
| Vendors | 18 |
Recent Clinical Trials for Lenabasum
| Title | Sponsor | Phase |
|---|---|---|
| Trial to Evaluate Efficacy and Safety of Lenabasum in Dermatomyositis | Corbus Pharmaceuticals Inc. | Phase 3 |
| Trial to Evaluate Efficacy and Safety of Lenabasum in Cystic Fibrosis | Cystic Fibrosis Foundation | Phase 2 |
| Trial to Evaluate Efficacy and Safety of Lenabasum in Cystic Fibrosis | Cystic Fibrosis Foundation Therapeutics | Phase 2 |
Clinical Trial Summary for Lenabasum
Top disease conditions for Lenabasum
Top clinical trial sponsors for Lenabasum
US Patents for Lenabasum
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Lenabasum | ⤷ Sign Up | Pre-spray emulsions and powders containing non-polar compounds | Virun, Inc. (Pomona, CA) | ⤷ Sign Up |
| Lenabasum | ⤷ Sign Up | Formulations of water-soluble derivatives of vitamin E and soft gel compositions, concentrates and powders containing same | Virun, Inc. (Pomona, CA) | ⤷ Sign Up |
| Lenabasum | ⤷ Sign Up | 4-phenylamino-quinazolin-6-yl-amides | Warner-Lambert Company LLC (Morris Plains, NJ) | ⤷ Sign Up |
| Lenabasum | ⤷ Sign Up | Method for treatment of HIV and diseases of immune dysregulation | ⤷ Sign Up | |
| Lenabasum | ⤷ Sign Up | 4-phenylamino-quinazolin-6-yl-amides | Warner-Lambert Company LLC (Morris Plains, NJ) | ⤷ Sign Up |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Lenabasum
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Lenabasum | Canada | CA2961829 | 2034-09-18 | ⤷ Sign Up |
| Lenabasum | European Patent Office | EP3193834 | 2034-09-18 | ⤷ Sign Up |
| Lenabasum | World Intellectual Property Organization (WIPO) | WO2016044805 | 2034-09-18 | ⤷ Sign Up |
| Lenabasum | World Intellectual Property Organization (WIPO) | WO2016044813 | 2034-09-18 | ⤷ Sign Up |
| Lenabasum | Canada | CA2961829 | 2034-09-18 | ⤷ Sign Up |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
